A study to assess the drug absorption into the blood after administration of 3 doses of AZD5718

Study identifier:D7550C00009

ClinicalTrials.gov identifier:NCT04087187

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, 3-period, 3-treatment, Single-dose, Open-label, Single-center, Crossover Study to Assess the Pharmacokinetics of 3 Doses of AZD5718

Medical condition

Coronary artery disease

Phase

Phase 1

Healthy volunteers

Yes

Study drug

Treatment A, Treatment B, Treatment C

Sex

All

Actual Enrollment

14

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 20 Sept 2019
Primary Completion Date: 31 Oct 2019
Study Completion Date: 31 Oct 2019

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Crossover Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Apr 2020 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

PAREXEL

Inclusion and exclusion criteria